These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 4381702)

  • 1. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic actions of a new coronary vasodilator agent, iproveratril.
    Hanna C; Schmid JR
    J Ark Med Soc; 1967 May; 63(12):455. PubMed ID: 4227477
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of antiarrhythmic and other cardiac activities in some newly synthesized quinazolone compounds.
    Singh N; Kulshrestha VK; Shamsi MA; Kohli RP; Bhargava KP
    Arch Int Pharmacodyn Ther; 1972; 198(1):94-106. PubMed ID: 5053244
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Actions of sparteine and sparteine derivatives on the heart and circulation].
    Raschack M
    Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
    Sano N; Kawada M; Fukutomi Y
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
    [No Abstract]   [Full Text] [Related]  

  • 13. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic properties of MJ 9067 in acute animal models.
    Byrne JE; Gomoll AW; McKinney GR
    J Pharmacol Exp Ther; 1977 Jan; 200(1):147-54. PubMed ID: 401883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.
    Gibala P; Sotníková R; Knezl V; Drímal J
    Arzneimittelforschung; 1987 Feb; 37(2):149-52. PubMed ID: 3580018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of combinations of verapamil and quinidine].
    Haas H; Raschack M; Fischer U
    Arzneimittelforschung; 1971 Sep; 21(9):1392-9. PubMed ID: 5171796
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of antiarrhythmic drugs in the prevention of recurrence of aconitine-induced atrial fibrillation after electrical conversion.
    Byrne JE; Dresel PE
    Can J Physiol Pharmacol; 1970 Feb; 48(2):90-7. PubMed ID: 4391942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.